[How safe is our treatment with heparins? (interview by Maria Weiss)].
Lindhoff-Last
E
E
D016907:Adverse Drug Reaction Reporting Systems; D000707:Anaphylaxis / Q000139:chemically induced* / Q000401:mortality; D000925:Anticoagulants / Q000008:administration & dosage / Q000633:toxicity*; D002681:China; D002809:Chondroitin Sulfates / Q000032:analysis / Q000633:toxicity*; D004340:Drug Contamination / Q000331:legislation & jurisprudence; D004342:Drug Hypersensitivity / Q000401:mortality*; D006493:Heparin / Q000008:administration & dosage / Q000633:toxicity*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000633:toxicity; D006801:Humans; D007262:Infusions, Intravenous; D006435:Renal Dialysis; D014481:United States
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D002809:Chondroitin Sulfates